| Appel d'offres Partiel Médicaments2023-3001-24-01 | Centre d'acquisitions gouvernementales | 2 708,96 $ | 23 juill. 2026 |
| Appel d'offres Partiel Médicaments2022-0550-37-03 | Centre d'acquisitions gouvernementales | 14 692,07 $ | 17 juin 2026 |
| Appel d'offres Partiel Médicaments2022-4777-47-02 | Centre d'acquisitions gouvernementales | 17 816,32 $ | 3 juin 2026 |
| Pharmaceuticals59093 | NWT Health and Social Services Authority | 26 544 $ | 13 avr. 2026 |
| Vaccins contre l'hépatite B GSKCW2447088 | Department of Public Works and Government Services (PSPC) | 9,5 M $ | 1 avr. 2026 |
| Contrat (GSK) - Fournir des vaccins contre la coquelucheCW2445891 | Department of Public Works and Government Services (PSPC) | 29,4 M $ | 30 mars 2026 |
| Contrat (GSK) - Fournir des vaccins contre la coquelucheCW2445891 | Department of Public Works and Government Services (PSPC) | 29,4 M $ | 30 mars 2026 |
| Drugs and Biologicals6D01253523 | Public Health Agency of Canada | 685,8 k $ | 10 mars 2026 |
| Vaccin contre le méningocoque B 2026 - GSKCW2439508 | Department of Public Works and Government Services (PSPC) | 3,1 M $ | 11 févr. 2026 |
| Pharmaceuticals56594 | NWT Health and Social Services Authority | 41 413,98 $ | 14 janv. 2026 |
| Pharmaceuticals55706 | NWT Health and Social Services Authority | 32 470 $ | 2 déc. 2025 |
| Pharmaceuticals47751 | NWT Health and Social Services Authority | 29 231,80 $ | 21 janv. 2025 |
| Modification 003 RelenzaCW2366910 | Department of Public Works and Government Services (PSPC) | 3,6 M $ | 28 juin 2024 |
| RelenzaCW2366910 | Department of Public Works and Government Services (PSPC) | 3,6 M $ | 28 juin 2024 |
| RelenzaCW2366910 | Department of Public Works and Government Services (PSPC) | 3,6 M $ | 28 juin 2024 |
| RelenzaCW2366910 | Department of Public Works and Government Services (PSPC) | 3,6 M $ | 28 juin 2024 |
| vaccins ROR, RORV et varicelleCW2355560 | Department of Public Works and Government Services (PSPC) | 66,1 M $ | 25 mars 2024 |
| vaccins ROR, RORV et varicelleCW2355560 | Department of Public Works and Government Services (PSPC) | 66,1 M $ | 25 mars 2024 |
| vaccins ROR, RORV et varicelleCW2355560 | Department of Public Works and Government Services (PSPC) | 66,1 M $ | 25 mars 2024 |
| Purchasing of Vaccine39558 | NWT Health and Social Services Authority | 45 207,55 $ | 4 mars 2024 |
| Purchasing of Pharmaceuticals38899 | NWT Health and Social Services Authority | 45 207,55 $ | 9 févr. 2024 |
| Pharmaceuticals38836 | NWT Health and Social Services Authority | 45 234,39 $ | 8 févr. 2024 |
| Drugs and BiologicalsHT24026072 | Health Canada | 26 075,88 $ | 29 juin 2023 |
| Pharmaceuticals32915 | NWT Health and Social Services Authority | 40 683 $ | 30 mai 2023 |
| Pharmaceuticals30192 | NWT Health and Social Services Authority | 40 683 $ | 16 févr. 2023 |
| Vaccins contre le méningocoque C et quadrivalentsCW2270374 | Department of Public Works and Government Services (PSPC) | 8,3 M $ | 25 janv. 2023 |
| Vaccins contre le méningocoque C et quadrivalentsCW2270374 | Department of Public Works and Government Services (PSPC) | 8,3 M $ | 25 janv. 2023 |
| Vaccins contre le méningocoque C et quadrivalentsCW2270374 | Department of Public Works and Government Services (PSPC) | 8,3 M $ | 25 janv. 2023 |
| Vaccin contre le méningocoque BCW2248786 | Department of Public Works and Government Services (PSPC) | 8,4 M $ | 10 janv. 2023 |
| Vaccin contre le méningocoque BCW2248786 | Department of Public Works and Government Services (PSPC) | 8,4 M $ | 10 janv. 2023 |